Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C13H6Cl5NO3 |
| Molecular Weight | 401.457 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
OC1=C(Cl)C=C(Cl)C=C1NC(=O)C2=C(Cl)C(Cl)=CC(Cl)=C2O
InChI
InChIKey=JYWIYHUXVMAGLG-UHFFFAOYSA-N
InChI=1S/C13H6Cl5NO3/c14-4-1-6(16)11(20)8(2-4)19-13(22)9-10(18)5(15)3-7(17)12(9)21/h1-3,20-21H,(H,19,22)
| Molecular Formula | C13H6Cl5NO3 |
| Molecular Weight | 401.457 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
DescriptionSources: https://goo.gl/hjMyxxCurator's Comment: The description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/25897961 | https://www.ncbi.nlm.nih.gov/pubmed/25771931
Sources: https://goo.gl/hjMyxx
Curator's Comment: The description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/25897961 | https://www.ncbi.nlm.nih.gov/pubmed/25771931
Oxyclozanide is a salicylanilide anthelmintic, used for the treatment and control of fascioliasis in cattle, sheep, and goats. The mechanism of action of oxyclozanide is the uncoupling of oxidative phosphorylation in flukes. It is formulated as an oral drench containing oxyclozanide only or in combination with levamisole hydrochloride or oxfendazole or as a powder to be incorporated in the feed. The recommended doses are 10 to 15 mg oxyclozanide/kg BW for cattle and 15 mg oxyclozanide/kg BW for sheep and goats. The application was amended to exclude sheep milk and goat tissues and milk.
CNS Activity
Sources: https://goo.gl/hjMyxx
Curator's Comment: Oxyclozanide caused liver and brain toxicity at the highest tested doses.
Originator
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL612860 Sources: https://www.ncbi.nlm.nih.gov/pubmed/25771931 |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
Sources: https://goo.gl/hjMyxx |
Curative | Unknown Approved UseUnknown |
Cmax
| Value | Dose | Co-administered | Analyte | Population |
|---|---|---|---|---|
15.87 μg/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/31234851/ |
10 mg/kg bw single, oral dose: 10 mg/kg bw route of administration: Oral experiment type: SINGLE co-administered: |
OXYCLOZANIDE plasma | Bos taurus population: HEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
27 mg/L |
12.5 mg/kg bw single, oral dose: 12.5 mg/kg bw route of administration: Oral experiment type: SINGLE co-administered: |
OXYCLOZANIDE plasma | Ovis aries population: UNKNOWN age: UNKNOWN sex: UNKNOWN food status: UNKNOWN |
AUC
| Value | Dose | Co-administered | Analyte | Population |
|---|---|---|---|---|
965.608 μg × h/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/31234851/ |
10 mg/kg bw single, oral dose: 10 mg/kg bw route of administration: Oral experiment type: SINGLE co-administered: |
OXYCLOZANIDE plasma | Bos taurus population: HEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
880 mg × h/L |
12.5 mg/kg bw single, oral dose: 12.5 mg/kg bw route of administration: Oral experiment type: SINGLE co-administered: |
OXYCLOZANIDE plasma | Ovis aries population: UNKNOWN age: UNKNOWN sex: UNKNOWN food status: UNKNOWN |
T1/2
| Value | Dose | Co-administered | Analyte | Population |
|---|---|---|---|---|
64.4 h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/31234851/ |
10 mg/kg bw single, oral dose: 10 mg/kg bw route of administration: Oral experiment type: SINGLE co-administered: |
OXYCLOZANIDE plasma | Bos taurus population: HEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
21.3 h |
12.5 mg/kg bw single, oral dose: 12.5 mg/kg bw route of administration: Oral experiment type: SINGLE co-administered: |
OXYCLOZANIDE plasma | Ovis aries population: UNKNOWN age: UNKNOWN sex: UNKNOWN food status: UNKNOWN |
Funbound
| Value | Dose | Co-administered | Analyte | Population |
|---|---|---|---|---|
1% |
12.5 mg/kg bw single, oral dose: 12.5 mg/kg bw route of administration: Oral experiment type: SINGLE co-administered: |
OXYCLOZANIDE plasma | Ovis aries population: UNKNOWN age: UNKNOWN sex: UNKNOWN food status: UNKNOWN |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Determination of bithionol, bromophen, nitroxynil, oxyclozanide, and tribromsalan in milk with liquid chromatography coupled with tandem mass spectrometry. | 2010-10-07 |
|
| Unchanged triclabendazole kinetics after co-administration with ivermectin and methimazole: failure of its therapeutic activity against triclabendazole-resistant liver flukes. | 2010-02-03 |
|
| Multi-residue determination of phenolic and salicylanilide anthelmintics and related compounds in bovine kidney by liquid chromatography-tandem mass spectrometry. | 2009-11-13 |
|
| The comparative efficacy of four anthelmintics against a natural acquired Fasciola hepatica infection in hill sheep flock in the west of Ireland. | 2009-10-14 |
|
| Drug discovery for schistosomiasis: hit and lead compounds identified in a library of known drugs by medium-throughput phenotypic screening. | 2009-07-14 |
|
| Efficacy of oxyclozanide against the rumen fluke Calicophoron daubneyi in experimentally infected goats. | 2009-05 |
|
| In Vitro Anthelmintic Activity of Baliospermum montanum Muell. Arg roots. | 2008-01 |
|
| [The investigation of short term efficiency of oxfendazole + oxyclozanide paste and tablet formulations against gastrointestinal nematodes in sheep]. | 2008 |
|
| [Concentration in plasma and excretion in milk of lactating cows after oral administration of tribromsalan, oxyclozanide and bromofenofos]. | 2006-12 |
|
| Analysis of the IgG antibody response against Paramphistomidae trematoda in naturally infected cattle. Application to serological surveys. | 2006-09-10 |
|
| Anthelmintic efficacy of genistein, the active principle of Flemingia vestita (Fabaceae): alterations in the free amino acid pool and ammonia levels in the fluke, Fasciolopsis buski. | 2004-12 |
|
| Worm control practices and anthelmintic usage in traditional and dairy cattle farms in the southern highlands of Tanzania. | 2003-05-15 |
|
| Antiprotozoals effective in vitro against the scuticociliate fish pathogen Philasterides dicentrarchi. | 2002-06-03 |
|
| Spectrophotometric multicomponent resolution of a veterinary formulation containing oxfendazole and oxyclozanide by multivariate calibration-prediction techniques. | 2002-05-15 |
|
| Activity of oxyclozanide, nitroxynil, clorsulon and albendazole against adult triclabendazole-resistant Fasciola hepatica. | 2001-06-09 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://goo.gl/hjMyxx
The recommended doses are 10 to 15 mg oxyclozanide/kg bw for cattle and 15 mg oxyclozanide/kg bw for sheep and goats
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/25897961
Oxyclozanide (5 mg/ml stock solution in DMSO) were tested by broth microdilution and disc diffusion assays in triplicate, adapted from established protocol. Broth microdilution was performed in triplicate in 96-well plates using Müller-Hinton broth (Becton Dickinson and Company, Franklin Lakes, NJ, USA). For testing MIC with daptomycin, the media was supplemented with CaCl2 at a final concentration of 50 μg/ml. The assay volume was 100 μl and twofold serial dilutions were carried out to get Oxyclozanide in the concentration range 0.0625–64 μg/ml. The bacterial concentration was adjusted to an initial OD600 of 0.03. After overnight incubation at 35°C, the absorbance was measured to determine antimicrobial activity. The minimum bactericidal concentration (MBC) was determined by plating 10 μl of culture volume from the MIC assay on Müller-Hinton agar and colony formation was examined after overnight incubation at 35°C. The lowest concentration at which colonies were not observed was regarded as the MBC.
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 17:58:10 GMT 2025
by
admin
on
Mon Mar 31 17:58:10 GMT 2025
|
| Record UNII |
1QS9G4876X
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WHO-VATC |
QP52AG06
Created by
admin on Mon Mar 31 17:58:10 GMT 2025 , Edited by admin on Mon Mar 31 17:58:10 GMT 2025
|
||
|
NCI_THESAURUS |
C250
Created by
admin on Mon Mar 31 17:58:10 GMT 2025 , Edited by admin on Mon Mar 31 17:58:10 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
16779
Created by
admin on Mon Mar 31 17:58:10 GMT 2025 , Edited by admin on Mon Mar 31 17:58:10 GMT 2025
|
PRIMARY | |||
|
DTXSID50177312
Created by
admin on Mon Mar 31 17:58:10 GMT 2025 , Edited by admin on Mon Mar 31 17:58:10 GMT 2025
|
PRIMARY | |||
|
m8327
Created by
admin on Mon Mar 31 17:58:10 GMT 2025 , Edited by admin on Mon Mar 31 17:58:10 GMT 2025
|
PRIMARY | Merck Index | ||
|
OXYCLOZANIDE
Created by
admin on Mon Mar 31 17:58:10 GMT 2025 , Edited by admin on Mon Mar 31 17:58:10 GMT 2025
|
PRIMARY | |||
|
2159
Created by
admin on Mon Mar 31 17:58:10 GMT 2025 , Edited by admin on Mon Mar 31 17:58:10 GMT 2025
|
PRIMARY | |||
|
CHEMBL2105450
Created by
admin on Mon Mar 31 17:58:10 GMT 2025 , Edited by admin on Mon Mar 31 17:58:10 GMT 2025
|
PRIMARY | |||
|
SUB09561MIG
Created by
admin on Mon Mar 31 17:58:10 GMT 2025 , Edited by admin on Mon Mar 31 17:58:10 GMT 2025
|
PRIMARY | |||
|
100000083282
Created by
admin on Mon Mar 31 17:58:10 GMT 2025 , Edited by admin on Mon Mar 31 17:58:10 GMT 2025
|
PRIMARY | |||
|
1QS9G4876X
Created by
admin on Mon Mar 31 17:58:10 GMT 2025 , Edited by admin on Mon Mar 31 17:58:10 GMT 2025
|
PRIMARY | |||
|
C66279
Created by
admin on Mon Mar 31 17:58:10 GMT 2025 , Edited by admin on Mon Mar 31 17:58:10 GMT 2025
|
PRIMARY | |||
|
218-904-0
Created by
admin on Mon Mar 31 17:58:10 GMT 2025 , Edited by admin on Mon Mar 31 17:58:10 GMT 2025
|
PRIMARY | |||
|
2277-92-1
Created by
admin on Mon Mar 31 17:58:10 GMT 2025 , Edited by admin on Mon Mar 31 17:58:10 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |